New research presented at the 2025 Annual Scientific Meeting of the American College of Allergy, Asthma and Immunology (ACAAI) offers encouraging news for parents of young children with peanut allergies. A long-term study found that a peanut patch treatment—epicutaneous immunotherapy—continued to help toddlers safely build tolerance to peanuts over three years.
This article was originally published on MedicalXpress.com

